Larson Financial Group »

Vyne Therapeutics shares owned by Larson Financial Group

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by Larson Financial Group from 13F filings

Historical chart of Larson Financial Group investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by Larson Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by Larson Financial Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $1 2 0.50

More positions owned by Larson Financial Group

Spdr Series Trust State Street Spd (SPYM)
Apple (AAPL)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
American Centy Etf Tr Us Quality Grow (QGRO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Franklin Templeton Etf Tr Us Mid Cp Mltfct (FLQM)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Capital Group Global Equity SHS (CGGE)
Applied Materials (AMAT)
Vanguard Index Fds Mid Cap Etf (VO)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Ishares Tr Msci Intl Qualty (IQLT)
Pgim Etf Tr Active Aggregate (PAB)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Microsoft Corporation (MSFT)

View all positions for Larson Financial Group

Top funds holding Vyne Therapeutics

Nantahala Capital Management
Lynx1 Capital Management
Shay Capital
Frigate Ventures
ADAR1 Capital Management
T3 Companies
Braidwell
Citadel Advisors
KVP Capital Advisors
Two Sigma Investments
Acadian Asset Management
Geode Capital Management
Ikarian Capital
Vanguard Capital Management
Vanguard Fiduciary Trust

View all funds holding Vyne Therapeutics